IMMUNOKINE
Cytokines coordinate immune responses by orchestrating communication between immune cells.
Disruption of these signaling networks plays a central role in autoimmune diseases, chronic inflammatory disorders,
and many other immune-mediated conditions.
01
Cytokine-based therapeutics have transformed treatment
for immune diseases, but conventional therapeutic approaches,
including recombinant proteins and monoclonal antibodies,
still face challenges in structural complexity, manufacturing,
tissue penetration, and cost.
02
IMMUNOKINE is designed to overcome these limitations by
combining artificial intelligence, structure-based design,
and peptide engineering to develop
next-generation cytokine-mimetic peptides capable of
precisely modulating immune signaling.
AI-Driven Engineering of Cytokine-Mimetic Peptides
IMMUNOKINE integrates computational design, structural biology, and peptide engineering to develop cytokine-mimetic peptides with high specificity for immune
receptors.
These peptides can be engineered as agonists, antagonists, or biased modulators depending on the therapeutic objective, enabling precise control of immune signaling
while preserving essential immune functions.
Built on peptide modality advantages, IMMUNOKINE supports flexible design and scalable application across immune-mediated diseases.
IMMUNOKINE continuously accumulates structure-based peptide design data, peptide libraries, candidate assets, and IP to strengthen future pipeline expansion.
Key Features
AI-powered structural analysis for next-generation cytokine-mimetic peptides
Highly selective regulation of immune signaling pathways
Supporting multiple therapeutic targets across diverse immune-mediated diseases
Continuous generation of proprietary peptide libraries, molecular designs, and intellectual property
The Future Envisioned by IMMUNOKINE :
Tailoring immune responses to the unique biology of each disease.
Precisely controlling cytokine signaling through AI-driven peptide engineering.
Expanding precision immunomodulation across a broad spectrum of immune-mediated diseases.
